AzTrials
AzTrials

AphasiaNCT03096015

Intensive Interdisciplinary Treatment Program for Individuals With Stroke-Induced Aphasia

A study testing Intensive Comprehensive Aphasia Program in people with Aphasia, run by Boston University Charles River Campus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An intensive, interdisciplinary treatment program was administered during the summer as part of regular clinic services in the Aphasia Resource Center (ARC) at Sargent College. This program was run program as described for three years. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Aphasia
What is being tested?
Intensive Comprehensive Aphasia Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
No sites listed yet
Study dates
Apr 2013to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of mild or moderate profile of aphasia secondary to a single stroke, as diagnosed by a certified speech-language pathologist.
  • Must be able to demonstrate auditory comprehension at a level that is functional for conversation.
  • Must demonstrate mobility or sensory deficits as a result of the stroke.
  • Must demonstrate cardiac/nutritional needs.
  • Must be able to ambulate without the physical assistance of another person for at least 500 feet.
  • Must be able to negotiate elevator and stairs independently
Show all 13Show fewer
  • Must be able to manage bathroom needs without assistance.
  • Must be more than twelve months post-onset of stroke.
  • Must be between 18 and 75 years of age.
  • Must be native speakers of English
  • Must have 8th grade level of education or higher.
  • Must have adequate vision for functional reading
  • Must have adequate hearing for conversation

Who cannot join

  • Subjects who meet the above inclusion criteria, but who are also bilingual, and/or have concomitant neurological disease will be excluded from the study.

About this study

An intensive, interdisciplinary treatment program was administered during the summer as part of regular clinic services in the Aphasia Resource Center (ARC) at Sargent College. This program was run program as described for three years. Not more than six native English speakers with mild or moderate profiles of aphasia and multidisciplinary rehabilitation needs (OT,PT, SLP and nutrition) were recruited from the Boston community to participate in an intensive interdisciplinary treatment program for four weeks during the month of June 2013. The program consists of approximately six hours of interdisciplinary treatment each day, five days per week over a four-week interval. Treatment is individualized using current evidence-based treatment approaches, which are commonly accepted protocols in clinical practice and will be administered by clinical faculty and staff from Speech-Language and Hearing Sciences, Occupational Therapy (OT), Physical Therapy (PT), the Center for Neurorehabilitation and Nutrition. Segments of these types of treatments are available for a small fee as part of our service in the Aphasia Resource Center; however, this comprehensive, interdisciplinary program is not available of this research study.

Approximately 30 hours of therapy per week are provided -- 6 hours per day over 5 days consisting of Speech-language Pathology, Physical Therapy, Occupational Therapy, and Nutrition Counseling.

Conditions
Aphasia
Being tested
Intensive Comprehensive Aphasia Program
Medical subject headings
Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive Comprehensive Aphasia ProgramBehavioural

Study groups in NCT03096015
Study groupRoleWhat they receive
Intensive Treatment for AphasiaExperimentalNot described
Receives: Behavioral: Intensive Comprehensive Aphasia Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stroke Impact Scale (to assess change)

    QoL indicator for stroke survivors

    Measured: 1 month pre intervention, immediately prior to intervention, the week post intervention, 3 months after intervention was completed

  2. Canadian Occupational Performance Measure (to assess change)

    Measures participation and satisfaction in meaningful activities

    Measured: 1 month pre intervention, immediately prior to intervention, the week post intervention, 3 months after intervention was completed

Secondary outcomes (1)
  1. Goal Attainment Scaling (to assess change)

    Measures attainment of individualized/personal community-based goals

    Measured: 1 month pre intervention, immediately prior to intervention, the week post intervention, 3 months after intervention was completed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2017
  2. Study startApr 2013
  3. Primary completionOct 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Within-subjects Group design
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03096015
Sponsor's protocol ID
3174E
Status last verified
Mar 2017
First submitted
21 Mar 2017
Last updated
30 Mar 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intensive Comprehensive Aphasia Program in people with Aphasia, run by Boston University Charles River Campus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stroke Impact Scale (to assess change) (time frame: 1 month pre intervention, immediately prior to intervention, the week post intervention, 3 months after intervention was completed). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2017; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in